NCT00895739 2013-08-12
Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure
National Cancer Institute (NCI)
Phase 2 Unknown
National Cancer Institute (NCI)
The Korean Society of Pediatric Hematology Oncology